Estimating the opportunity costs of bed-days

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

(2015) Karl Claxton et al.   HEALTH TECHNOLOGY ASSESSMENT

Systematic overview of cost–effectiveness thresholds in ten countries across four continents

(2015) Ruth Schwarzer et al.   Journal of Comparative Effectiveness Research

Disability weights for the Global Burden of Disease 2013 study

(2015) Joshua A Salomon et al.   Lancet Global Health

Increasing Access to Specialty Surgical Care

(2014) Eric J. Leroux et al.   ANNALS OF SURGERY

Valuation of Hospital Bed-Days Released by Infection Control Programs: A Comparison of Methods

(2014) Andrew J. Stewardson et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Opportunity Cost of Funding Drugs for Rare Diseases

(2014) Doug Coyle et al.   MEDICAL DECISION MAKING

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

(2014) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room

(2014) Simon Eckermann et al.   PHARMACOECONOMICS

Kinky Thresholds Revisited: Opportunity Costs Differ in the NE and SW Quadrants

(2014) Simon Eckermann   Applied Health Economics and Health Policy

Twenty Years of Using Economic Evaluations for Drug Reimbursement Decisions: What Has Been Achieved?

(2013) M. Drummond   JOURNAL OF HEALTH POLITICS POLICY AND LAW

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

(2013) Don Husereau et al.   VALUE IN HEALTH

Principles of Economics Crucial to Pharmacy Students' Understanding of the Prescription Drug Market

(2011) Gail B. Rattinger et al.   AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION

Response to comment on article by Jit et al. “The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe”

(2011) Mark Jit et al.   VACCINE

Estimating the Cost of Health Care–Associated Infections: Mind Your p’s and q’s

(2010) Nicholas Graves et al.   CLINICAL INFECTIOUS DISEASES

Opportunity cost in the evaluation of surgical innovations: a case study of laparoscopic versus open colectomy

(2009) Abhishek Chatterjee et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES